COLUMBIA, Md., Jan. 31 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK), a DHA omega-3 market leader, announced today that leading DHA researcher and expert Dr. Norman Salem, Jr., will be joining Martek Biosciences on February 4, 2008, as vice president and chief scientific officer.
Dr. Salem is one of the world's leading researchers on DHA and the functions of polyunsaturated fatty acids and lipids. He comes to Martek after 30 years with The National Institutes of Health where he led the internationally recognized Laboratory of Membrane Biochemistry and Biophysics. His latest scientific work focused on the role of DHA in neural development as well as how DHA is made in the body and incorporated into the brain and other organs.
As Martek's chief scientific officer, Dr. Salem will be responsible for leading clinical research, discovery, microbial biotechnology, and analytical sciences and will support the efforts of scientific affairs and medical research.
Dr. Salem received his B.S. degree in physics from Miami University and his Ph.D. in neurobiology from the University Of Rochester School Of Medicine. During his career, Dr. Salem has published over 200 research articles and book chapters. He was the 2002 recipient of the Supelco/Nicholas Pelick Research Award from the American Oil Chemists Society, which recognizes outstanding original research in fats, oils, lipid chemistry, or biochemistry. He currently serves as a research professor in the Department of Pediatrics at the F. Edward Hebert School of Medicine of Uniformed Services University of the Health Sciences.
"We are pleased to welcome Dr. Salem, a prominent expert on the science
of DHA, to Martek. His scientific knowledge and exp
|SOURCE Martek Biosciences Corporation|
Copyright©2008 PR Newswire.
All rights reserved